Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-α, soluble TNFR2 and altered TNF-α signaling

Journal of Neuroimmunology

Volumn 166, Issue 1-2, 2005, Pages 65-74

  Hooper, Laura C ^a   Chin, Marian S ^a   Detrick, Barbara ^b   Hooks, John J ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cytokine receptors; Cytokines; Inflammation; Viral

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE EXPRESSION; HEMOCONCENTRATION; IMMUNE RESPONSE; IMMUNITY; INJECTION; MALE; MOLECULE; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA; RETINA DEGENERATION; RETINOPATHY; SERUM; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; CORONAVIRUS INFECTIONS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERFERON-ALPHA; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MONOCYTES; MURINE HEPATITIS VIRUS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OSMOLAR CONCENTRATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RETINA; RETINAL DEGENERATION; SIGNAL TRANSDUCTION; SOLUBILITY; STAINING AND LABELING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23044451461     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.05.018     Document Type: Article

References (37)

1. T. Akaike, and H. Maeda Nitric oxide and virus infection Immunology 101 2000 300 308
2. C. Bartholdy, A. Nansen, O. Marker, and A.R. Thomsen Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity Clin. Exp. Immunol. 116 1999 299 306
3. B. Cheng, S. Christakos, and M.P. Mattson Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homostasis Neuron 12 1994 139 153
4. L. Connelly, M. Palacios-Callender, C. Ameixa, S. Moncada, and A.J. Hobbs Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide J. Immunol. 166 2001 3873 3881
5. A.P. Cope, D. Aderka, M. Doherty, H. Engelmann, D. Gibbons, A.C. Jones, F.M. Brennan, R.N. Maini, D. Wallach, and M. Feldmann Increased levels of soluble tumor-necrosis-factor receptors in the sera and synovial-fluid of patients with rheumatoid arthritis Arthritis Rheum. 35 1992 1160 1169
6. A.P. Cope, M. Londei, N. Randall-Chu, S.B.A. Cohen, M.J. Eliot, F.M. Brennan, R.N. Maini, and M. Feldmann Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis J. Clin. Invest. 94 1994 749 760
7. A.P. Cope, R.S. Liblau, X.-D. Yang, M. Congia, C. Laudanna, R.D. Schreiber, L. Probert, G. Kollias, and H.O. McDevitt Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling J. Exp. Med. 185 1997 1573 1584
8. M.H. Godfried, T. Vanderpoll, J.W. Mulder, G.J. Weverling, E. Endert, J.M.A. Lange, and H.P. Sauerwein Soluble tumor-necrosis-factor receptors as surrogate markers for the assessment of zidovudine treatment in asyptomatic HIV-1 infection J. Acquir. Immune Defic. Syndr. 10 1995 531 539
9. J.A. Gross, J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, M. Moore, A. Littau, A. Grossman, H. Haugen, K. Foley, H. Blumberg, K. Harrison, W. Kindsvogel, and C.H. Clegg TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature 404 2000 995 999
10. B. Heilig, M. Wermann, H. Gallati, M. Brockhaus, B. Berke, O. Egen, A. Pezzutto, and W. Hunstein Elevated TNF receptor plasma-concentrations in patients with rheumatoid-arthritis Clin. Investig. 70 1992 22 27
11. B. Heilig, C. Fiehn, M. Brockhaus, H. Gallati, A. Pezzutto, and W. Hunstein Evaluation of soluble tumor-necrosis-factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic-sclerosis, and mixed connective-tissue disease J. Clin. Immunol. 13 1993 321 328
12. J.J. Hooks, C. Percopo, Y. Wang, and B. Detrick Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy J. Immunol. 151 1993 3381 3389
13. J.J. Hooks, Y. Wang, and B. Detrick The critical role of IFN-gamma in experimental coronavirus retinopathy Invest. Ophthalmol. Vis. Sci. 44 2003 3402 3408
14. Y. Itoh, T. Okanoue, N. Ohnishi, M. Sakamoto, K. Nishioji, Y. Nakagawa, M. Minami, Y. Murakami, and K. Kashims Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection Am. J. Gastroenterol. 94 1999 1332 1340
15. C.O. Jacob, S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea Prevention of diabetes in non-obese diabetic mice by tumor necrosis factor (TNF)-similarities between TNFa and interleukin-1 Proc. Natl. Acad. Sci. U. S. A. 87 1990 968 972
16. D. Kagi, A. Ho, B. Odermatt, A. Zakarian, P.S. Ohashi, and T.W. Mak TNF receptor-1-dependent b cell toxicity as an effector pathway in autoimmune diabetes J. Immunol. 162 1999 4598 4605
17. B. Kulseng, L. Vatten, and T. Espevik Soluble tumor necrosis factor receptor in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease Acta Diabetol. 36 1999 99 105
18. G.A. Limb, H. Soomro, S. Janikoun, R.D. Hollifield, and J. Shilling Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy Clin. Exp. Immunol. 115 1999 409 414
19. J. Liu, M.W. Marino, G. Wong, D. Grail, A. Dunn, J. Bettadapura, A.J. Slavin, L. Old, and C.C.A. Bernard TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination Nat. Med. 4 1998 78 83
20. G. Marinos, N.V. Naoumov, S. Rossol, F. Torre, P.Y.N. Wong, H. Gallati, B. Portmann, and R. Williams Tumor-necrosis-factor receptors in patients with chronic hepatitis-B virus-infection Gastroenterology 108 1995 1453 1463
21. W. Niedbala, X.Q. Wei, C. Campbell, D. Thomson, M. Komai-Koma, and F.Y. Liew Effects of nitric oxide on the induction and differentiation of Th1 cells Eur. J. Immunol. 29 1999 2498 2505
22. W. Niedbala, X.Q. Wei, C. Campbell, D. Thomson, M. Komai-Koma, and F.Y. Liew Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP Proc. Natl. Acad. Sci. 99 2002 16186 16191
23. J.Y. Niederkorn, E. Mayhem, J. Mellon, and S. Hegde Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival Invest. Ophthalmol. Vis. Sci. 45 2004 2674 2679
24. J.J. O'Shea, A. Ma, and P. Lipsky Cytokines and autoimmunity Nat. Rev., Immunol. 2 2002 37 45
25. K.A. Pape, A. Khoruts, A. Mondino, and M.K. Jenkins Inflammatory cytokines enhance the in-vivo clonal expansion and differentiation of antigen-activated CD4+ T cells J. Immunol. 159 1997 591 598
26. S. Realdon, P. Pontisso, F. Adami, L. Trentin, F. Noventa, A. Ferrari, I. Migliorato, A. Gatta, and A. Alberti High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders J. Hepatol. 34 2001 723 729
27. T. Robak, A. Gladalska, and H. Stepien The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis Eur. Cytokine Netw. 9 1998 145 154
28. S.G. Robbins, C.P. Hamel, B. Detrick, and J.J. Hooks Murine coronavirus induces an acute and long-lasting disease of the retina Lab. Invest. 62 1990 417 426
29. S.G. Robbins, B. Detrick, and J.J. Hooks Murine coronavirus is retinotropic when introduced by several direct routes and one indirect one and long-lasting disorder can result after coronavirus infection Invest. Ophthalmol. Vis. Sci. 32 1991 1883 1893
30. M. Robertson, J. Liversidge, J.V. Forrester, and A.D. Dick Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental uveoretinitis Invest. Ophthalmol. Vis. Sci. 44 2003 3034 3041
31. M. Saura, C. Zaragoza, C. Bao, A. McMillan, and C.J. Lowenstein Interaction of interferon regulatory factor-1 and nuclear factor kB during activation of inducible nitric oxide synthase transcription J. Mol. Biol. 289 1999 459 471
32. B.D. Sippy, F.M. Hofman, D. Wallach, and D.R. Hinton Increased expression of tumor-necrosis-alpha receptors in the brains of patients with AIDS J. Acquir. Immune Defic. Syndr. 10 1995 511 521
33. D.E. Speiser, E. Sebada, T. Ohteki, M.F. Bachmann, K. Pfeffer, T.W. Mak, and P.S. Ohashi Tumour necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo Eur. J. Immunol. 26 1996 3055 3060
34. A. StudnickaBenke, G. Steiner, P. Petera, and J.S. Smolen Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus Br. J. Rheumatol. 35 1996 1067 1074
35. S.A. Vinores, Y. Wang, M.A. Vinores, N.L. Derevjanik, A. Shi, D.A. Klein, B. Detrick, and J.J. Hooks Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains J. Neuroimmunol. 119 2001 175 182
36. Y. Wang, M. Burnier, B. Detrick, and J.J. Hooks Genetic predisposition to coronavirus-induced retinal disease Invest. Ophthalmol. Vis. Sci. 37 1996 250 254
37. L. Zheng, G. Fisher, R.E. Miller, J. Peshon, D.H. Lynch, and M.J. Leonardo Induction of apoptosis in mature T cells by tumor necrosis factor Nature 377 1995 348 351